Damora Therapeutics (DMRA) Exchange Rate Effect (2019 - 2026)
Damora Therapeutics (DMRA) reported Exchange Rate Effect of -$48000.0 for Q1 2026, down 123.65% on a YoY basis from $203000.0 in Q1 2025, and down 166.67% quarter-over-quarter from -$18000.0 in Q4 2025.
Damora Therapeutics (DMRA) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Damora Therapeutics has reported Exchange Rate Effect for 8 years, with the latest figure at -$48000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 123.65% year-over-year to -$48000.0; the trailing twelve-month figure through Mar 2026 stood at $454000.0 (up 1846.15% YoY), and the FY2025 full-year result was $705000.0, up 322.4% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$48000.0, down from -$18000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.5 million in Q4 2022, with the low at -$720000.0 in Q2 2022.
- Historically, Exchange Rate Effect has averaged $58117.6 across 5 years, with a median of -$18000.0 in 2025.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 949.15% — and 2024, when it sank 563.16%.
- Damora Therapeutics' Exchange Rate Effect stood at $1.5 million in 2022, then plunged by 81.3% to $281000.0 in 2023, then plunged by 301.78% to -$567000.0 in 2024, then jumped by 96.83% to -$18000.0 in 2025, then plunged by 166.67% to -$48000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$48000.0 (Q1 2026), -$18000.0 (Q4 2025), and $11000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - | -48,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48,000.00 |
| Mar 31, 2026 | -48,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Dec 31, 2025 | -18,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 509,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Mar 31, 2025 | 203,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Dec 31, 2024 | -567,000.00 |
| Sep 30, 2024 | 467,000.00 |
| Sep 30, 2024 | 467,000.00 |
| Jun 30, 2024 | -129,000.00 |
| Jun 30, 2024 | -129,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Mar 31, 2024 | -88,000.00 |
| Dec 31, 2023 | 281,000.00 |
| Dec 31, 2023 | 281,000.00 |